Venus Medtech's market value is the price at which a share of Venus Medtech trades on a public exchange. It measures the collective expectations of Venus Medtech investors about its performance. Venus Medtech is trading at 0.27 as of the 27th of December 2025. This is a 10 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.27. With this module, you can estimate the performance of a buy and hold strategy of Venus Medtech and determine expected loss or profit from investing in Venus Medtech over a given investment horizon. Check out Venus Medtech Correlation, Venus Medtech Volatility and Venus Medtech Alpha and Beta module to complement your research on Venus Medtech.
Please note, there is a significant difference between Venus Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Venus Medtech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Venus Medtech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Venus Medtech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Venus Medtech's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Venus Medtech.
0.00
11/27/2025
No Change 0.00
0.0
In 31 days
12/27/2025
0.00
If you would invest 0.00 in Venus Medtech on November 27, 2025 and sell it all today you would earn a total of 0.00 from holding Venus Medtech or generate 0.0% return on investment in Venus Medtech over 30 days. Venus Medtech is related to or competes with Avita Medical, BICO Group, Cellink AB, 3-D Matrix, Paxman AB, Jushi Holdings, and Molecular Partners. Venus Medtech Inc. develops and commercializes transcatheter heart valve medical devices in Mainland China and internati... More
Venus Medtech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Venus Medtech's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Venus Medtech upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Venus Medtech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Venus Medtech's standard deviation. In reality, there are many statistical measures that can use Venus Medtech historical prices to predict the future Venus Medtech's volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Venus Medtech. Your research has to be compared to or analyzed against Venus Medtech's peers to derive any actionable benefits. When done correctly, Venus Medtech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Venus Medtech.
Venus Medtech Backtested Returns
Venus Medtech owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.15, which indicates the firm had a -0.15 % return per unit of risk over the last 3 months. Venus Medtech exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Venus Medtech's Variance of 30.54, risk adjusted performance of (0.09), and Coefficient Of Variation of (686.66) to confirm the risk estimate we provide. The entity has a beta of 2.73, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Venus Medtech will likely underperform. At this point, Venus Medtech has a negative expected return of -0.82%. Please make sure to validate Venus Medtech's kurtosis, as well as the relationship between the day median price and period momentum indicator , to decide if Venus Medtech performance from the past will be repeated at some point in the near future.
Auto-correlation
0.00
No correlation between past and present
Venus Medtech has no correlation between past and present. Overlapping area represents the amount of predictability between Venus Medtech time series from 27th of November 2025 to 12th of December 2025 and 12th of December 2025 to 27th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Venus Medtech price movement. The serial correlation of 0.0 indicates that just 0.0% of current Venus Medtech price fluctuation can be explain by its past prices.
Correlation Coefficient
0.0
Spearman Rank Test
0.5
Residual Average
0.0
Price Variance
0.0
Venus Medtech lagged returns against current returns
Autocorrelation, which is Venus Medtech pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Venus Medtech's pink sheet expected returns. We can calculate the autocorrelation of Venus Medtech returns to help us make a trade decision. For example, suppose you find that Venus Medtech has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Venus Medtech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Venus Medtech pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Venus Medtech pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Venus Medtech pink sheet over time.
Current vs Lagged Prices
Timeline
Venus Medtech Lagged Returns
When evaluating Venus Medtech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Venus Medtech pink sheet have on its future price. Venus Medtech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Venus Medtech autocorrelation shows the relationship between Venus Medtech pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Venus Medtech.
Other Information on Investing in Venus Pink Sheet
Venus Medtech financial ratios help investors to determine whether Venus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Venus with respect to the benefits of owning Venus Medtech security.